189 related articles for article (PubMed ID: 10517874)
21. Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer.
Ross JS; Sheehan CE; Ambros RA; Nazeer T; Jennings TA; Kaufman RP; Fisher HA; Rifkin MD; Kallakury BV
Am J Surg Pathol; 1999 Mar; 23(3):296-301. PubMed ID: 10078920
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
23. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy.
Sengupta S; Cheville JC; Lohse CM; Zincke H; Myers RP; Riehle DL; Pankratz VS; Blute ML; Sebo TJ
Urology; 2006 Jul; 68(1):94-8. PubMed ID: 16844452
[TBL] [Abstract][Full Text] [Related]
24. Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome.
Hammarsten P; Josefsson A; Thysell E; Lundholm M; Hägglöf C; Iglesias-Gato D; Flores-Morales A; Stattin P; Egevad L; Granfors T; Wikström P; Bergh A
Mod Pathol; 2019 Sep; 32(9):1310-1319. PubMed ID: 30980038
[TBL] [Abstract][Full Text] [Related]
25. An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancer.
Uzoaru I; Rubenstein M; Mirochnik Y; Slobodskoy L; Shaw M; Guinan P
J Surg Oncol; 1998 Jan; 67(1):33-7. PubMed ID: 9457254
[TBL] [Abstract][Full Text] [Related]
26. In treating localized prostate cancer the efficacy of cryoablation is independent of DNA ploidy type.
Bahn DK; Silverman P; Lee F; Badalament R; Bahn ED; Rewcastle JC
Technol Cancer Res Treat; 2004 Jun; 3(3):253-7. PubMed ID: 15161318
[TBL] [Abstract][Full Text] [Related]
27. [DNA ploidy and the S-phase fraction and their prognostic significance in gastrointestinal tumors].
Kusano M; Kushibe A; Ito K; Kino S; Mito M
Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1086-9. PubMed ID: 1944160
[TBL] [Abstract][Full Text] [Related]
28. DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cure.
Borre M; Høyer M; Nerstrøm B; Overgaard J
Prostate; 1998 Sep; 36(4):244-9. PubMed ID: 9719024
[TBL] [Abstract][Full Text] [Related]
29. Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma.
Nativ O; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
J Urol; 1990 Aug; 144(2 Pt 1):303-6. PubMed ID: 1695690
[TBL] [Abstract][Full Text] [Related]
30. Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features.
Greene DR; Rogers E; Wessels EC; Wheeler TM; Taylor SR; Santucci RA; Thompson TC; Scardino PT
J Urol; 1994 May; 151(5):1301-7. PubMed ID: 8158775
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma.
Centeno BA; Zietman AL; Shipley WU; Sobczak ML; Shipley JW; Preffer FI; Boyle BJ; Colvin RB
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):309-15. PubMed ID: 7928459
[TBL] [Abstract][Full Text] [Related]
32. DNA ploidy, Gleason score, pathological stage and serum PSA levels as predictors of disease-free survival in C-D1 prostatic cancer patients submitted to radical retropubic prostatectomy.
Di Silverio F; D'Eramo G; Buscarini M; Sciarra A; Casale P; Di Nicola S; Loreto A; Seccareccia F; De Vita R
Eur Urol; 1996; 30(3):316-21. PubMed ID: 8931963
[TBL] [Abstract][Full Text] [Related]
33. DNA ploidy measured on archived pretreatment biopsy material may correlate with prostate-specific antigen recurrence after prostate brachytherapy.
Keyes M; Macaulay C; Hayes M; Korbelik J; Morris WJ; Palcic B
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):829-34. PubMed ID: 23688814
[TBL] [Abstract][Full Text] [Related]
34. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM
Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401
[TBL] [Abstract][Full Text] [Related]
35. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
36. The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer.
Lennartz M; Minner S; Brasch S; Wittmann H; Paterna L; Angermeier K; Öztürk E; Shihada R; Ruge M; Kluth M; Koop C; Wilczak W; Krech T; Lebok P; Wittmer C; Heinzer H; Steuber T; Adam M; Huland H; Graefen M; Haese A; Simon R; Sauter G; Schlomm T
Clin Cancer Res; 2016 Jun; 22(11):2802-11. PubMed ID: 26813356
[TBL] [Abstract][Full Text] [Related]
37. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer.
Frankfurt OS; Chin JL; Englander LS; Greco WR; Pontes JE; Rustum YM
Cancer Res; 1985 Mar; 45(3):1418-23. PubMed ID: 3971384
[TBL] [Abstract][Full Text] [Related]
38. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors.
Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ
Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493
[TBL] [Abstract][Full Text] [Related]
39. An analysis of clinical and treatment related prognostic factors on outcome using biochemical control as an end-point in patients with prostate cancer treated with external beam irradiation.
Horwitz EM; Vicini FA; Ziaja EL; Dmuchowski CF; Stromberg JS; Gustafson GS; Martinez AA
Radiother Oncol; 1997 Sep; 44(3):223-8. PubMed ID: 9380820
[TBL] [Abstract][Full Text] [Related]
40. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer.
Golusinski W; Olofsson J; Szmeja Z; Biczysko W; Krygier-Stojałowska A; Kulczyński B
Eur Arch Otorhinolaryngol; 1999; 256(6):306-11. PubMed ID: 10456281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]